Abbvie Inc
NYSE:ABBV
Abbvie Inc
Other Current Assets
Abbvie Inc
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Other Current Assets
$4.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Assets
$2.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Assets
$2.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Assets
$623.7m
|
CAGR 3-Years
27%
|
CAGR 5-Years
35%
|
CAGR 10-Years
39%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Assets
$386.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
Seagen Inc
NASDAQ:SGEN
|
Other Current Assets
$151.9m
|
CAGR 3-Years
38%
|
CAGR 5-Years
42%
|
CAGR 10-Years
39%
|
See Also
What is Abbvie Inc's Other Current Assets?
Other Current Assets
4.9B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Other Current Assets amounts to 4.9B USD.
What is Abbvie Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
9%
Over the last year, the Other Current Assets growth was 12%. The average annual Other Current Assets growth rates for Abbvie Inc have been 11% over the past three years , 21% over the past five years , and 9% over the past ten years .